↓ Skip to main content

How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?

Overview of attention for article published in Frontiers in immunology, March 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter
43 X users
patent
2 patents

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?
Published in
Frontiers in immunology, March 2020
DOI 10.3389/fimmu.2020.00492
Pubmed ID
Authors

Morgane Denis, Michael Duruisseaux, Marie Brevet, Charles Dumontet

X Demographics

X Demographics

The data shown below were collected from the profiles of 43 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 16%
Other 6 12%
Student > Bachelor 6 12%
Researcher 5 10%
Student > Master 4 8%
Other 5 10%
Unknown 15 31%
Readers by discipline Count As %
Medicine and Dentistry 17 35%
Immunology and Microbiology 6 12%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Biochemistry, Genetics and Molecular Biology 4 8%
Arts and Humanities 1 2%
Other 2 4%
Unknown 15 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 November 2023.
All research outputs
#1,294,096
of 25,477,125 outputs
Outputs from Frontiers in immunology
#1,122
of 31,773 outputs
Outputs of similar age
#33,344
of 391,562 outputs
Outputs of similar age from Frontiers in immunology
#25
of 604 outputs
Altmetric has tracked 25,477,125 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,773 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 391,562 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 604 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.